1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow JTT 305: new trials by email Literature Review of JTT 305 trials Research Report on JTT 305
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) MK-5442, Placebo to MK-5442, Alendronate Sodium - Osteoporosis, Postmenopausal Osteoporosis | Phase 2 | Completed | Merck Sharp & Dohme LLC | 526 | 2009-11-01 | 2016-01-22 |
| A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001) MK-5442, Placebo, Vitamin D3 - Osteoporosis | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 383 | 2009-10-01 | 2015-02-18 |
Osteoporosis (2) · Osteoporosis, Postmenopausal (1)
PMID 25166719, PMID 26556736, PMID 33606045
2009 (2)